Journal List > Korean J Pediatr Gastroenterol Nutr > v.14(3) > 1043508

Korean J Pediatr Gastroenterol Nutr. 2011 Sep;14(3):232-244. Korean.
Published online September 30, 2011.  https://doi.org/10.5223/kjpgn.2011.14.3.232
Copyright © 2011 The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition
Organic Upper Digestive Diseases in Children with Chronic Abdominal Pain
Soo Hee Chang, M.D.
Department of Pediatrics, Bundang Jesaeng General Hospital, Seongnam, Korea.

Corresponding author (Email: csh5015@dmc.or.kr )
Received September 03, 2011; Accepted September 07, 2011.

Abstract

Organic diseases are prevalent in about 5 to 10% of children with chronic abdominal pain. The most common diseases of the upper digestive tract include gastroesophageal reflux disease (GERD), chronic gastritis with or without Helicobacter pylori (H. pylori), and peptic ulcer. The H. pylori infections acquired during childhood persist lifelong without eradication. Although the majority of H. pylori infected children remain asymptomatic, H. pylori infection may cause various digestive and extra-digestive diseases. There are still debates about a causal relationship between H. pylori-gastritis and abdominal symptoms in the absence of peptic ulcer disease. The number of Korean children infected with antibiotic resistant H. pylori is increasing even though the prevalence decreases after eradication. The choices of rescue therapy are limited in children after eradication failure. Antioxidant supplements with regimens against H. pylori have been tried with limited effects. Here I wanted to review the findings of recent reports on common upper digestive diseases such as GERD, peptic ulcer, and H. pylori infection in children with chronic abdominal pain.

Keywords: Chronic abdominal pain; Organic disease; H. pylori infection

References
1. Seo JK, Chi JG, Kim EC. Gastrofiberscopic findings and Helicobacter pylori gastritis in children with recurrent abdominal pain. J Korean Pediatr Soc 1992;35:1646–1656.
2. Kalach N, Bonkems P, Koletzko S, Mourad-Baars P, Shcherbakov P, Celinska-Cedro D, et al. Frequency and risk factors of gastric and duodenal ulcers or erosions in children-a prospective 1-month European multicenter study. Eur J Gastroenterol Hepatol 2010;22:1174–1181.
3. Thakkar K, Dorsey F, Gilger MA. Impact of endoscopy on management of chronic abdominal pain in children. Dig Dis Sci 2011;56:488–493.
4. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900–1920.
quiz 1943.
5. Nelson SP, Chen EH, Syniar GM, Christoffel KK. the Pediatric Practice Research Group. Prevalence of symptoms of gastroesophageal reflux during childhood. A pediatric practice-based survey. Arch Pediatr Adolesc Med 2000;154:150–154.
6. Kwon HJ, Yi DY, Ryoo E, Cho KH, Son DW, Tcha H. Prevalence and risk factors associated with esophagitis in children with abdominal pain. Korean J Pediatr Gastroenterol Nutr 2008;11:103–109.
7. Gold BD. Outcomes of pediatric gastroesophageal reflux disease: In the first year of life, childhood and adults. Oh, and should we really leave Helicobacter pylori alone? J Pediatr Gastroenterol Nutr 2003;37:S33–S39.
8. Vandenplas Y, Rudolph CD, Di Lorenzo C, Hasall E, Liptak G, Mazur L, et al. Pediatric gastroesophageal reflux clinical practice guidelines: Joint recommendations of the North American Society for Pediatric Gastroenteroloty, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (EPSGHAN). J Pediatr Gastroenterol Nutr 2009;49:498–547.
9. Boccia G, Manguso F, Miele E, Buonavolontá R, Staiano A. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable? Am J Gastroenterol 2007;102:1291–1297.
10. Tam YH, Lee KH, To YF, Chan KW, Cheung ST. Helicobacter pylori-positive versus Helicobacter pylori-negative idiopathic peptic ulcers in children with their long-term outcomes. J Pediatr Gastroenterol Nutr 2009;48:299–305.
11. Oderda G, Mura S, Valori A, Brustia R. Idiopathic peptic ulcers in children. J Pediatr Gastroenterol Nutr 2009;48:268–270.
12. Seo JK, Yang HR. Characteristic features of H. pylori infection in children. Hanyang Med Rev 2007;27:65–75.
13. Kim NY, Kim JJ, Choe YH, Kim HS, Kim JI, Chung IS. Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea. Korean J Gastroenterol 2009;54:269–278.
14. Seo JK, Ko JS, Choi KD. Serum ferritin and Helicobacter pylori infection in children: a sere-epidemiologic study in Korea. J Gastroenterol Hepatol 2002;17:754–757.
15. Handa O, Naito Y, Yoshikawa T. Helicobacter pylori: a ROS-inducing bacterial species in the stomach. Inflamm Res 2010;59:997–1003.
16. Ko JS, Chung JY, Bae SH, Kim EJ, Seo JK. Relation between recurrent abdominal pain and Helicobacter pylori infection and the role of cag A and vac A in pediatric Helicobacter pylori infection. Korean J Gastroenterol 2001;37:167–172.
17. Ko JY, Kim YJ, Park HY, Choe YH, Jeon BH, Oh YJ, et al. Genotypes of the Helicobacter pylori vac A signal sequence differ with age in Korea. Korean J Helicobacter Up Gastrointest Res 2004;4:15–20.
18. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772–781.
19. Seo JK. Role of endoscopy in the diagnosis and management of peptic ulcer disease in children. Sin Paediatr J 1999;41:264–271.
20. Choe YH, Ko JS, Kim SY, Yoo YM, Seo JK. The eradication of Helicobacter pylori in the duodenal ulcer and the duodenal recurrence. Korean J Pediatr Gastroenterol Nutr 1998;1:30–36.
21. Na SY, Seo JK. Helicobacter pylori infection in children with recurrent abdominal pain. Korean J Pediatr Gastroenterol Nutr 2005;8:1–11.
22. Spee LAA, Madderom MB, Pijpers M, Leeuwen YV, Berger MY. Association between Helicobacter pylori and gastrointestinal symptoms in children. Pediatrics 2010;125:e651–e669.
23. Yuan W, Yumin L, Kehu Y, Bin M, Quanlin G, Donghai W, et al. Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials. Scand J Gastroenterol 2010;45:665–676.
24. Qu XH, Huang XL, Xiong P, Zhu CY, Huang YL, Lu LG, et al. Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis. World J Gastroenterol 2010;16:886–896.
25. Thankachan P, Muthayya S, Sierksma A, Eilander A, Thomas T, Duchateau GS, et al. Helicobacter pylori infection does not influence the efficacy of iron and vitamin B12 fortification in marginally nourished Indian children. Eur J Clin Nutr 2010;64:1101–1107.
26. Choe YH, Kim SK, Hong YC. The relationship between Helicobacter pylori infection and iron-deficiency: seroprevalence study in 937 pubescent children. Arch Dis Child 2003;88:178.
27. Choe YH, Kim SK, Son BK, Lee DH, Hong YC, Pai SH. Randomized placebo-controlled trial of Helicobacter pylori eradication for iron-deficiency anemia in preadolescent children and adolescents. Helicobacter 1999;4:135–139.
28. Pacifico L, Anania C, Osborn JF, Ferraro F, Chiesa C. Consequences of Helicobacter pylori infection in children. World J Gastroenterol 2010;16:5181–5194.
29. Kindermann A, Lopes AI. Helicobacter pylori in Pediatrics. Helicobacter 2009;14 Suppl 1:52–57.
30. Windle HJ, Kelleher D, Crabtree JE. Childhood Helicobacter pylori infection and growth impairment in developing countries: a vicious cycle? Pediatrics 2007;119:e754–e759.
31. Choe YH, Lee JE, Kim SK, Hong YC. Helicobacter pylori infection with iron deficiency anemia and subnormal growth at puberty. Arch Dis Child 2000;82:136–140.
32. Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 2010;15:1–20.
33. Koletzko S, Jones NL, Goodman KJ, Gold B, Rowland M, Cadranel S, et al. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr. 2011
Publish Ahead of Print Version Available at http://www.naspghan.org.
34. Choi JG, Jang JY, Kim JS, Park HY, Choe YH, Kim KM. Efficacy of two triple eradication regimens in children with Helicobacter pylori infection. J Korean Med Sci 2006;21:1037–1040.
35. Oderda G, Shcherbakov P, Bontems P, Urruzuno P, Romano C, Gottrand F, et al. Results from the pediatric European register for treatment of Helicobacter pylori (PERTH). Helicobacter 2007;12:150–156.
36. Ko JS, Yang HR, Seo JK. Detection of 23S rRNA mutation associated with clarithromycin resistance in children with Helicobacter pylori infection. Korean J Pediatr Gastroenterol Nutr 2004;7:137–142.
37. Kim YM, Lee YJ, Oh SH, Sung H, Kim M, Kim KM. Antimicrobial resistance of Helicobacter pylori isolated from Korean children. Korean J Pediatr Gastroenterol Nutr 2011;14:45–51.
38. Chiesa C, Pacifico L, Anania C, Poggiogalle E, Chiarelli F, Osborn JF. Helicobacter pylori therapy in children: overview and challenge. Int J Immunopathol Pharmacol 2010;23:405–416.
39. Orenstein SR. Clinical trials report: optimal treatment of Helicobacter pylori gastric infection in children. Curr Gastroenterol Rep 2010;12:157–159.
40. Dore MP, Leandro G, Realdi G, Sepulveda AR, Grahan DY. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci 2000;45:68–76.
41. Schwarzer A, Urruzuno P, Iwanczak B, Martinez-Gomez ME, Kalach N, Roma-Giammikon E, et al. New effective treatment regimen for children infected with a double resistant Helicobacter pylori strain. J Pediatr Gastroenterol Nutr 2011;52:424–428.
42. Francavilla R, Lionetti E, Castellaneta SP, Magista AM, Boscarelli G, Piscitelli D, et al. Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children; a randomized trial. Gastroenterology 2005;129:1414–1419.
43. Francavilla R, Lionetti E, Castellaneta S, Margiotta M, Piscitelli D, Lorenzo L, et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. J Pediatr 2010;157:228–232.
44. Lionetti E, Indrio F, Pavone L, Borrelli G, Cavallo L, Franvavilla R. Role of probiotics in pediatric patients with Helicobacter pylori infection: a comprehensive review of the literature. Helicobacter 2010;15:79–87.
45. Akcam M. Helicobacter pylori and micronutrients. Indian Pediatrics 2010;47:119–126.
46. DovhanJ J, Kljakc K, Dodig-Curkovic K, Curković M, Volarević M, Marjanović K. Helicobacter pylori, zinc, and iron in oxidative stress-induced injury of gastric mucosa. Mini Rev Med Chem 2009;9:26–30.
47. Salgueiro J, Zubillaga M, Goldman C, Barrado A, Martinez Sarrasague M, Leonardi N, et al. Review article: is there a link between micronutrient malnutrition and Helicobacter pylori infection? Aliment Pharmacol Ther 2004;20:1029–1034.
48. Park JH, Kim SY, Kim DW, Lee WG, Rhee KH, Youn HS. Correlation between Helicobacter pylori infection and vitamin C levels in whole blood, plasma, and gastric juice in Korean children. J Pediatr Gastroenterol Nutr 2003;37:53–62.
49. Jarosz M, Dzieniszewski J, Dabrowska-Ufniarz E, Wartanowicz M, Ziemlanski S, Reed PI. Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice. Eur J Cancer Prev 1998;7:449–454.
50. Chuang CH, Sheu BS, Kao AW, Cheng HC, Huang AH, Yang HB, et al. Adjuvant effect of vitamin C on Omeprzole-Amoxicillin-Clarithromycin triple therapy for Helicobacter pylori eradication. Hepato-Gastroenterology 2007;54:320–324.
51. Zojaji H, Talaie R, Mirsattari D, Haghazali M, Molaei M, Mohsenian N, et al. The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation. Dig Liver Dis 2009;41:644–647.
52. Sezikli M, Çetinkaya ZA, Sezikli H, Güzelbulut F, TiftikÇi A, Ince AT, et al. Oxidative stress in Helicobacter pylori infection: Does supplementation with vitamin C and E increase the eradication rate? Helicobacter 2009;14:280–285.
53. Chuang CH, Sheu BS, Huang AH, Yang HB, Wu JJ. Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection. Helicobacter 2002;7:310–316.
54. Rokkas T, Papatheodorou G, Karameris A, Mavrogeorgis A, Kalogeropoulos N, Giannikos N. Helicobacter pylori infection and gastric juice vitamin C levels; impact of eradication. Dig Dis Sci 1995;40:615–621.
55. Hep A, Posisilova J, Dolina J, Prasek J, Dite P. Levels of vitamins A, E, and C in serum and gastric juice in relation to gastric mucosa and occurrence of Helicobacter pylori. Vnitr Lek 1998;44:396–399.
56. Zhang YY, Xia HH, Zhuang ZH, Zhong J. Review article: 'true' re-infection of Helicobacter pylori after successful eradication--worldwide annual rates, risk factors and clinical implications. Aliment Pharmacol Ther 2009;29:145–160.
57. Shim JO, Seo JK. Helicobacter pylori reinfection rate by a 13C-urea breath test and endoscopic biopsy tests in Korean children. Korean J Pediatr 2006;49:268–272.
58. Broussard CS, Goodman KJ, Phillips CV, Smith MA, Fischbach LA, Day RS, et al. Antibiotics taken for other illnesses and spontaneous clearance of Helicobacter pylori infection in children. Pharmacoepidemiol Drug Saf 2009;18:722–729.
59. Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter 2007;12:89–102.